Comparison of influenza and COVID-19–associated hospitalizations among children < 18 years old in the United States — FluSurv-NET (October–April 2017–2021) and COVID-NET (October 2020–September 2021)

Abstract

Background: Influenza virus and SARS-CoV-2 are significant causes of respiratory illness in children. Methods: Influenza and COVID-19-associated hospitalizations among children &lt;18 years old were analyzed from FluSurv-NET and COVID-NET, two population-based surveillance systems with similar catchment areas and methodology. The annual COVID-19-associated hospitalization rate per 100 000 during the ongoing COVID-19 pandemic (October 1, 2020-September 30, 2021) was compared to influenza-associated hospitalization rates during the 2017-18 through 2019-20 influenza seasons. In-hospital outcomes, including intensive care unit (ICU) admission and death, were compared. Results: Among children &lt;18 years old, the COVID-19-associated hospitalization rate (48.2) was higher than influenza-associated hospitalization rates: 2017-18 (33.5), 2018-19 (33.8), and 2019-20 (41.7). The COVID-19-associated hospitalization rate was higher among adolescents 12-17 years old (COVID-19: 59.9; influenza range: 12.2-14.1), but similar or lower among children 5-11 (COVID-19: 25.0; influenza range: 24.3-31.7) and 0-4 (COVID-19: 66.8; influenza range: 70.9-91.5) years old. Among children &lt;18 years old, a higher proportion with COVID-19 required ICU admission compared with influenza (26.4% vs 21.6%; p&lt;0.01). Pediatric deaths were uncommon during both COVID-19- and influenza-associated hospitalizations (0.7% vs 0.5%; p=0.28). Conclusions: In the setting of extensive mitigation measures during the COVID-19 pandemic, the annual COVID-19-associated hospitalization rate during 2020-2021 was higher among adolescents and similar or lower among children &lt;12 years old compared with influenza during the three seasons before the COVID-19 pandemic. COVID-19 adds substantially to the existing burden of pediatric hospitalizations and severe outcomes caused by influenza and other respiratory viruses.

Comparison of influenza and COVID-19 hospitalizations in British Columbia, Canada: a population-based study

“…In a US-based surveillance study focused on children, the COVID-19 hospitalization rate from October 2020–September 2021 was similar/lower to historical influenza seasons among children 0-11, but higher among adolescents aged 12–17. 27…”

Inpatient and Outpatient Differences in Pediatric Patients with Laboratory-confirmed COVID-19

“…DOI: 10.1097/INF.0000000000003388 M ultisystem inflammatory syndrome in children (MIS-C) is a newly described severe hyperinflammatory multisystem illness specific to the pediatric population, which is thought to be an immune-mediated complication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. 1,2 Our center managed 2 distinct cohorts of MIS-C patients, each following periods of maximal virus circulation and surge (waves) in our community by 4-6 weeks. Multiple centers (including ours) and consortia, as well as the CDC, have published key demographic and clinical features of MIS-C following the first wave of patients with this rare presentation.…”

Intent among Parents to Vaccinate Children before Pediatric Vaccine Recommendations, Minnesota and Los Angeles County, California--May-September 2021

“…Child and adolescent COVID-19-related hospitalizations increased five-fold in the US between June and August 2021 and unvaccinated adolescents experienced elevated rates of hospitalization and serious illness compared to their vaccinated peers. 1,2 This increase occurred during the emergence of the SARS-CoV-2 Delta variant (B.1.617.2) and while schools and parents prepared for return to in-person school for the 2021-2022 school year after having transitioned to remote learning during the initial stages of the COVID-19 pandemic. 3 The Food and Drug Administration expanded authorization of the Pfizer-BioNTech COVID-19 vaccine in May 2021 to include individuals aged 12-15 years.…”